IL322685A - תבניות פירוק דנ" א נטולי תאים שמקורן בדלפי מבדילות בין תתי-סוגים היסטולוגיים של סרטן ריאות בצורה לא פולשנית - Google Patents
תבניות פירוק דנ" א נטולי תאים שמקורן בדלפי מבדילות בין תתי-סוגים היסטולוגיים של סרטן ריאות בצורה לא פולשניתInfo
- Publication number
- IL322685A IL322685A IL322685A IL32268525A IL322685A IL 322685 A IL322685 A IL 322685A IL 322685 A IL322685 A IL 322685A IL 32268525 A IL32268525 A IL 32268525A IL 322685 A IL322685 A IL 322685A
- Authority
- IL
- Israel
- Prior art keywords
- cfdna
- coverage
- transcription factor
- fragment
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- Data Mining & Analysis (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Databases & Information Systems (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Evolutionary Computation (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Hospice & Palliative Care (AREA)
- Bioethics (AREA)
- Artificial Intelligence (AREA)
- Primary Health Care (AREA)
- Oncology (AREA)
- Software Systems (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363445284P | 2023-02-13 | 2023-02-13 | |
| US202363470101P | 2023-05-31 | 2023-05-31 | |
| US202363528237P | 2023-07-21 | 2023-07-21 | |
| PCT/US2024/015444 WO2024173277A2 (en) | 2023-02-13 | 2024-02-12 | Delfi-derived cell-free dna fragmentation patterns differentiate histologic subtypes of lung cancers in a non-invasive manner |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL322685A true IL322685A (he) | 2025-10-01 |
Family
ID=92420632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL322685A IL322685A (he) | 2023-02-13 | 2024-02-12 | תבניות פירוק דנ" א נטולי תאים שמקורן בדלפי מבדילות בין תתי-סוגים היסטולוגיים של סרטן ריאות בצורה לא פולשנית |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4665867A2 (he) |
| JP (1) | JP2026506641A (he) |
| KR (1) | KR20250151418A (he) |
| CN (1) | CN120752348A (he) |
| AU (1) | AU2024223105A1 (he) |
| CO (1) | CO2025012211A2 (he) |
| IL (1) | IL322685A (he) |
| MX (1) | MX2025009394A (he) |
| WO (1) | WO2024173277A2 (he) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026051992A1 (en) * | 2024-09-04 | 2026-03-12 | Centre For Novostics | Fragmentomics in cerebrospinal fluid |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240015054A (ko) * | 2020-12-21 | 2024-02-02 | 더 존스 홉킨스 유니버시티 | 무세포 dna 단편화를 이용한 폐암 검출 |
| CA3214321A1 (en) * | 2021-04-08 | 2022-10-13 | Nicholas C. Dracopoli | Method of detecting cancer using genome-wide cfdna fragmentation profiles |
| EP4320618A4 (en) * | 2021-04-08 | 2025-08-27 | Fred Hutchinson Cancer Center | METHOD FOR ANALYZING CELL-FREE DNA SEQUENCE DATA TO EXAMINE NUCLEOSOME PROTECTION AND CHROMATIN ACCESSIBILITY |
-
2024
- 2024-02-12 EP EP24757501.2A patent/EP4665867A2/en active Pending
- 2024-02-12 KR KR1020257029298A patent/KR20250151418A/ko active Pending
- 2024-02-12 IL IL322685A patent/IL322685A/he unknown
- 2024-02-12 CN CN202480016300.0A patent/CN120752348A/zh active Pending
- 2024-02-12 AU AU2024223105A patent/AU2024223105A1/en active Pending
- 2024-02-12 WO PCT/US2024/015444 patent/WO2024173277A2/en not_active Ceased
- 2024-02-12 JP JP2025546413A patent/JP2026506641A/ja active Pending
-
2025
- 2025-08-11 MX MX2025009394A patent/MX2025009394A/es unknown
- 2025-09-09 CO CONC2025/0012211A patent/CO2025012211A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN120752348A (zh) | 2025-10-03 |
| EP4665867A2 (en) | 2025-12-24 |
| JP2026506641A (ja) | 2026-02-25 |
| MX2025009394A (es) | 2025-11-03 |
| KR20250151418A (ko) | 2025-10-21 |
| WO2024173277A2 (en) | 2024-08-22 |
| WO2024173277A3 (en) | 2024-10-24 |
| CO2025012211A2 (es) | 2025-09-29 |
| AU2024223105A1 (en) | 2025-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4320618A2 (en) | Cell-free dna sequence data analysis method to examine nucleosome protection and chromatin accessibility | |
| US20250182892A1 (en) | Method of monitoring cancer using fragmentation profiles | |
| Chen et al. | Plasma cell-free DNA methylomes for hepatocellular carcinoma detection and monitoring after liver resection or transplantation | |
| IL322685A (he) | תבניות פירוק דנ" א נטולי תאים שמקורן בדלפי מבדילות בין תתי-סוגים היסטולוגיים של סרטן ריאות בצורה לא פולשנית | |
| US20250075273A1 (en) | Method of detecting cancer using genome-wide cfdna fragmentation profiles | |
| Wu et al. | Finding gastric cancer related genes and clinical biomarkers for detection based on gene–gene interaction network | |
| Parasramka et al. | Validation of gene expression signatures to identify low-risk clear-cell renal cell carcinoma patients at higher risk for disease-related death | |
| US20260106037A1 (en) | Incorporating clinical risk into biomarker-based assessment for cancer pre-screening | |
| US20250327130A1 (en) | Use of cell-free dna fragmentomes in the diagnostic evaluation of patients with signs and symptoms suggestive of cancer | |
| Mehta et al. | The Prevalence of Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Cancer: An Experience From Tertiary Care Hospital | |
| US20250263795A1 (en) | Methods for classification of tissue samples as positive or negative for cancer | |
| WO2025213080A2 (en) | Systems and methods for detection of non-coding rnas | |
| Huang et al. | PRDM1: a useful indicator of differentiation and prognosis in esophageal squamous cell carcinoma | |
| CN121380335A (zh) | 生物标志物在局部进展期胃癌术后腹膜复发诊断/预测中的应用 | |
| Shern | Single-cell tumor microenvironment profiling informs a circulating proteome test for the interception of malignant transformation in NF1 nerve sheath tumors | |
| WO2025006618A1 (en) | Systems and methods for analysis of small rna k-mers | |
| Rafaelsen et al. | Local staging of sigmoid colonic cancer using MRI |